KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 61 filers reported holding KRONOS BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | – | 308 | +180.0% | 0.00% | – |
| Q1 2024 | $0 | – | 110 | -47.9% | 0.00% | – |
| Q4 2023 | $0 | -100.0% | 211 | -96.8% | 0.00% | – |
| Q3 2023 | $8,000 | +166.7% | 6,514 | +183.1% | 0.00% | – |
| Q1 2023 | $3,000 | -66.7% | 2,301 | -60.0% | 0.00% | – |
| Q4 2022 | $9,000 | -75.0% | 5,751 | -46.6% | 0.00% | – |
| Q3 2022 | $36,000 | -5.3% | 10,776 | +2.5% | 0.00% | – |
| Q2 2022 | $38,000 | -58.2% | 10,510 | -17.0% | 0.00% | – |
| Q1 2022 | $91,000 | -62.4% | 12,666 | -28.7% | 0.00% | – |
| Q4 2021 | $242,000 | +108.6% | 17,773 | +221.0% | 0.00% | – |
| Q3 2021 | $116,000 | +31.8% | 5,537 | +51.4% | 0.00% | – |
| Q2 2021 | $88,000 | +31.3% | 3,658 | +60.2% | 0.00% | – |
| Q1 2021 | $67,000 | +76.3% | 2,283 | +78.9% | 0.00% | – |
| Q4 2020 | $38,000 | – | 1,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $3,428,989 | 3.75% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,609,469 | 0.39% |
| Acuitas Investments, LLC | 443,457 | $549,887 | 0.29% |
| CM Management, LLC | 135,000 | $167,400 | 0.15% |
| Privium Fund Management (UK) Ltd | 292,182 | $341,853 | 0.13% |
| Alphabet Inc. | 1,438,232 | $1,783,408 | 0.09% |
| Forefront Analytics, LLC | 134,998 | $167,400 | 0.08% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 1,665,797 | $2,044,488 | 0.04% |
| Artal Group S.A. | 842,954 | $1,045,263 | 0.03% |
| VESTIA PERSONAL WEALTH ADVISORS | 15,718 | $19,490 | 0.02% |